Drug Information
Drug (ID: DG00437) and It's Reported Resistant Information
Name |
Tetraphenylphosphonium bromide
|
||||
---|---|---|---|---|---|
Synonyms |
Tetraphenylphosphonium bromide; 2751-90-8; Phosphonium, tetraphenyl-, bromide; Phosphonium, tetraphenyl-, bromide (1:1); tetraphenylphosphanium;bromide; MFCD00011915; Tetraphenylphosponium bromide; Tetraphenylphosphoniumbromide; tetraphenylphosphanium,bromide; EINECS 220-393-4; Ph4PBr; Bromotetraphenylphosphorane; C24H20BrP; Tetraphenylphosphorus bromide; SCHEMBL42616; CHEMBL456063; DTXSID30883722; BCP24497; Tetraphenylphosphonium bromide, 97%; NSC115672; TETRAPHENYL-PHOSPHONIUM-BROMIDE; AKOS015833052; AKOS025117489; CS-W013858; NSC 115672; NSC-115672; AS-12560; DB-047239; FT-0634467; T1069; A819099; W-107108; Tetraphenylphosphonium bromide, Vetec(TM) reagent grade, 97%
Click to Show/Hide
|
||||
Structure | |||||
Drug Resistance Disease(s) |
Disease(s) with Clinically Reported Resistance for This Drug
(1 diseases)
Salmonellosis [ICD-11: 1A09]
[1]
|
||||
Click to Show/Hide the Molecular Information and External Link(s) of This Drug | |||||
Formula |
C24H20BrP
|
||||
IsoSMILES |
C1=CC=C(C=C1)[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4.[Br-]
|
||||
InChI |
1S/C24H20P.BrH/c1-5-13-21(14-6-1)25(22-15-7-2-8-16-22,23-17-9-3-10-18-23)24-19-11-4-12-20-24;/h1-20H;1H/q+1;/p-1
|
||||
InChIKey |
BRKFQVAOMSWFDU-UHFFFAOYSA-M
|
||||
PubChem CID |
Type(s) of Resistant Mechanism of This Drug
IDUE: Irregularity in Drug Uptake and Drug Efflux
Drug Resistance Data Categorized by Their Corresponding Diseases
ICD-01: Infectious/parasitic diseases
Salmonellosis [ICD-11: 1A09]
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Efflux pump membrane transporter MdsA (MDSA) | [1] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsB (MDSB) | [1] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. | |||
Key Molecule: Efflux pump membrane transporter MdsC (MDSC) | [1] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Disease | Salmonella enterica infection [ICD-11: 1A09.0] | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica serovar Typhimurium ATCC 14028s | 588858 | ||
Experiment for Molecule Alteration |
Quantitative real-time PCR | |||
Experiment for Drug Resistance |
L agar plate method assay | |||
Mechanism Description | Overexpression or overproduction of MdsABC confers drug resistance. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.